News & analysis
Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032 and others. The company's geographical segments include Europe (of which Sweden), the United States, Japan, Australia, and Other geographical areas.Camurus AB is a research based pharmaceutical company engaged in the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, with better treatment outcomes and quality of life.
Latest CAMX News